Traditionally, pharmaceutical marketers relied on in-person detailing, samples, emails, print ads, speaker programs, conferences, websites, and DTC ads to promote drugs and influence key treatment decision-makers. In-person interaction with key treatment decision-makers is the bedrock of pharmaceutical marketing, and it contributes to a significant proportion of pharmaceutical marketing spend. However, social distancing and COVID-19 protocols limited in-person interactions, driving pharmaceutical companies towards digital adoption. Read more about the digital adoption landscape in Egypt in our latest white paper.